Literature DB >> 11342446

Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.

T Sakai, K Nosaka, S Tamiya, S Koga, S Mita, M Uchino, H Mitsuya, M Matsuoka.   

Abstract

Opportunistic infections frequently occur in patients with adult T-cell leukemia (ATL) and human T-cell leukemia virus type I (HTLV-I) carriers. However, the underlying mechanisms of such infections remain unknown. To clarify the mechanism of immunodeficiency in those infected with HTLV-I, this study analyzed the T-cell subsets in HTLV-I carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis and ATL using 3-color fluorescence with CD62L and CD45RA coexpression either with CD4(+) or CD8(+) T cells. The number of naive T lymphocytes was markedly suppressed in patients with ATL, particularly in those with acute form, compared with uninfected control individuals. The number of naive T cells was low in HTLV-I-infected individuals under 50 years old compared with uninfected individuals, whereas the number of memory T lymphocytes was greater in HTLV-I-infected individuals. Although the increase of memory T lymphocytes correlated with HTLV-I provirus loads, no relationship was found between naive T-cell counts and provirus loads. T-cell receptor rearrangement excision circles (TRECs), which are generated by DNA recombination during early T lymphopoiesis, were quantified to evaluate thymic function in HTLV-I-infected individuals. TREC levels were lower in HTLV-I-infected individuals than in uninfected individuals. In HTLV-I carriers less than 70 years old, an increase of Epstein-Barr virus DNA in peripheral blood mononuclear cells was observed in 6 of 16 (38%) examined, whereas it was detectable in only 1 of 11 uninfected controls. These results suggested that the low number of naive T lymphocytes was due to suppressed production of T lymphocytes in the thymus, which might account for immunodeficiency observed in HTLV-I-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342446     DOI: 10.1182/blood.v97.10.3177

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

2.  De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.

Authors:  Paola Miyazato; Jun-ichirou Yasunaga; Yuko Taniguchi; Yoshio Koyanagi; Hiroaki Mitsuya; Masao Matsuoka
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.

Authors:  Nicolas Thiault; Julie Darrigues; Véronique Adoue; Marine Gros; Bénédicte Binet; Corine Perals; Bertrand Leobon; Nicolas Fazilleau; Olivier P Joffre; Ellen A Robey; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Nat Immunol       Date:  2015-05-04       Impact factor: 25.606

4.  TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.

Authors:  Guangyong Ma; Jun-ichirou Yasunaga; Hirofumi Akari; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

5.  Prevalence of human T cell lymphotropic virus 1 infection in Canada.

Authors:  L Amar; M Le; F M Ghazawi; E Rahme; A Segal; E Netchiporouk; G Popradi; L Moreau; O Roshdy; D Sasseville; I V Litvinov
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

6.  Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes.

Authors:  Mélanie Wencker; Céline Sausse; David Derse; Louis Gazzolo; Madeleine Duc Dodon
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia.

Authors:  Takero Shindo; Kazutaka Kitaura; Hiroshi Ureshino; Kazuharu Kamachi; Masaharu Miyahara; Kazuko Doi; Tatsuro Watanabe; Eisaburo Sueoka; Tadasu Shin-I; Ryuji Suzuki; Shinya Kimura
Journal:  Oncoimmunology       Date:  2017-12-11       Impact factor: 8.110

Review 8.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 9.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

10.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.